Alpha 2.0
Login Register
» Articles » PMID: 22732465

TB Diagnostic Capacity in Sub-Saharan African HIV Care Settings

Overview
Journal J Acquir Immune Defic Syndr
Specialty Infectious Diseases
Date 2012 Jun 27
PMID 22732465
Citations 18
Authors
Suzue Saito
Andrea A Howard
Michael J A Reid
Batya Elul
Anna Scardigli
Sabine Verkuijl
Alaine U Nyaruhirira
Denis Nash
Affiliations
Soon will be listed here.
Abstract

As HIV care services continue to scale-up in sub-Saharan Africa, adequate tuberculosis diagnostic capacity is vital to reduce mortality among HIV-infected persons. A structured survey was administered at 663 health facilities providing HIV care to 908,043 patients in across 9 sub-Saharan African countries to estimate the proportion of facilities and HIV patients at these facilities with access TB-related diagnostic tests. Sputum smear microscopy was available at 87% of facilities (representing 97% of patients), chest x-ray at 26% of facilities (representing 56% of patients), tuberculin skin tests were available at 12% of facilities (representing 33% of patients). Acid-fast bacillus culture was available on-/off-site at 53% of facilities (representing 77% of patients). Primary health facilities had lower availability of tuberculosis diagnostic tests compared with secondary and tertiary health facilities. As HIV care continues to decentralize to primary health facilities, a corresponding expansion of diagnostic capacity to lower levels of the health system will be essential.

Citing Articles

Mortality and associated factors among adult patients on tuberculosis treatment in Tanzania: A retrospective cohort study.

Bukundi E, Mhimbira F, Kishimba R, Kondo Z, Moshiro C J Clin Tuberc Other Mycobact Dis. 2021; 24:100263.

PMID: 34355068 PMC: 8322306. DOI: 10.1016/j.jctube.2021.100263.

Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala.

Garcia J, Melendez J, Alvarez R, Mejia-Chew C, Kelley H, Sidiki S AIDS Res Ther. 2020; 17(1):62.

PMID: 33076996 PMC: 7570414. DOI: 10.1186/s12981-020-00318-8.

Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium.

Humphrey J, Mpofu P, Pettit A, Musick B, Carter E, Messou E Open Forum Infect Dis. 2020; 7(1):ofaa006.

PMID: 32010735 PMC: 6984675. DOI: 10.1093/ofid/ofaa006.

Viral pneumonia in adults and older children in sub-Saharan Africa - epidemiology, aetiology, diagnosis and management.

Ho A Pneumonia (Nathan). 2019; 5(Suppl 1):18-29.

PMID: 31641571 PMC: 5922328. DOI: 10.15172/pneu.2014.5/446.

Symptom screening for active tuberculosis in pregnant women living with HIV.

LaCourse S, Cranmer L, Bekker A, Steingart K, Black D, Horne D Cochrane Database Syst Rev. 2018; 2018(1).

PMID: 29910691 PMC: 5997280. DOI: 10.1002/14651858.CD012934.

References
1.
Getahun H, Harrington M, OBrien R, Nunn P . Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007; 369(9578):2042-2049. DOI: 10.1016/S0140-6736(07)60284-0. View
2.
Akolo C, Adetifa I, Shepperd S, Volmink J . Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010; (1):CD000171. PMC: 7043303. DOI: 10.1002/14651858.CD000171.pub3. View
3.
Marais B, Pai M . New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev. 2007; 8(2):124-33. DOI: 10.1016/j.prrv.2007.04.002. View
4.
Reid M, Shah N . Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009; 9(3):173-84. DOI: 10.1016/S1473-3099(09)70043-X. View
5.
Blakemore R, Story E, Helb D, Kop J, Banada P, Owens M . Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010; 48(7):2495-501. PMC: 2897495. DOI: 10.1128/JCM.00128-10. View